Atlas Trials

Persistence of Immune Response Six Years After One Dose of 9vHPV Vaccine Among Male and Female Students

Clinical trial NCT07156084 · RECRUITING

Trial details

NCT number
NCT07156084
Sponsor
Canadian Immunization Research Network
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
HPV Vaccine
Start date
2025-09-23
Primary completion
2026-02-01
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.